Unfinished Business on the Glass Ceiling
Reflecting on my career and the significant societal and technological shifts…
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the…
Happy Anniversary to Us!
I grew up in the Midwest — the middle child in a large family. We were each…
Hybrid Work Strategies: 3 Tips to Transform Engagement
In this post-COVID era, our clients have experienced a culture shift — driven…
What’s the Latest?
There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your…
Gen Z Advice for Seasoned Boomers
“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective luddites.” That’s how…
The Truth about Teams
When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are…
Running the Biopharma Marathon
When I moved to Boston over thirty years ago, I had never even heard of the Boston Marathon. I grew up in the Midwest and moved to the West Coast for…
Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as this topic is very much a part of…
Patient Advocacy – Delivering on Patient Centricity in Drug Development
Historically, biopharma companies developed drugs for patients with an illness — but the illness was the primary focus. In recent years, much has…
Survival in Uncertain Times
Like so many seasoned industry professionals, we eagerly seek thought leader perspectives — on the current biopharma industry landscape; the…
